To further investigate the role of CSF3 in TGF-β1 signaling in IPF pathogenesis, we silenced TGF-β receptor II (TGF-βRII) in HLF treated with rCSF3. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.